ARCHIVED: this archived Practice Note is no longer maintained and is for background information only. Following publication of the government’s COVID-19 Response: Living with COVID-19, under which the remaining coronavirus (COVID-19) domestic legal restrictions were removed in England from 24 February 2022, the ICO replaced its detailed, specific guidance with a brief form of guidance on data protection and COVID-19 from 28 March 2022. See: LNB News 28/03/2022 91. This Practice Note considers the position under the ICO’s previous, more detailed, guidance, which was deleted from 28 March 2022. This material considers the UK GDPR regime, and legislative links are to Assimilated Regulation (EU) 2016/679, UK GDPR, except where expressly stated otherwise. The coronavirus (COVID-19) pandemic is likely to give rise to situations that will require an employer to process, ie to collect, use and record, personal data and special category data relating to its workforce, in particular data concerning health (health information). Before processing any such data, the employer will need to consider whether that processing is lawful under Assimilated Regulation

A number of competition authorities around the world are reacting in order to adapt to the impact caused by the coronavirus (COVID-19) outbreak. The table below tracks and summarises coronavirus (COVID-19) related developments in relation to antitrust investigations/claims, exceptions/exemptions, new legislation and State aid investigations. For a summary of changes to merger control procedures in highlighted jurisdictions, see further: MJ merger control—competition authorities and coronavirus (COVID-19) status NOTE—this tracker only covers developments within its scope that have been made publicly available. It is not intended (nor purports to be) an exhaustive or definitive resource. Coronavirus (COVID-19) related antitrust investigations/claims Jurisdiction Case name, companies under investigation and industry Issues Developments Albania Personal protection products• Numerous pharmaceutical companies (listed here) Price-gouging • Infringement decision issued—15/10/2020• Investigations launched—18/03/2020 Armenia PCR tests• 11 undertakings Restrictive agreements • Investigations launched—26/11/2021 Medical gloves• Unknown Price-gouging • Investigation terminated—27/08/2020• Investigations launched—27/05/2020 Masks• Unknown Price-gouging • Investigation terminated—27/08/2020• Investigations launched—26/05/2020 Azerbaijan Medicines and masks• Buta Farm LLC• Olive Pharmaceuticals LLC• Vita Pharmaceuticals LLC• Intermed Plyus LLC• Dokta LLC Price-gouging • Investigations launched—13/03/2020 Brazil Masks, goggles and protection filters• Inmadica Andina Price-gouging •

This tracker was used to track key developments, legislation, guidance and briefing notes relating to the initial response to coronavirus (COVID-19) between March and May 2020, focusing on updates relevant to local government governance. It is designed to provide a historical record of the legislation and guidance in place and used during that period. For current developments, see: Coronavirus (COVID-19)—governance tracker [Archived]. Click on the links below to jump to the relevant section: • Primary legislation • National restrictions • Local authority governance • Financial Support • Other legislation • Government guidance • Other sources of information • News Analysis • Case law Primary legislation Development When in force Find out more Corporate Insolvency and Governance Act 2020 Comes into force partly on 26 June 2020, and fully on such day as the Secretary of State may by regulations appoint. Act making provision for companies in financial difficulty and amends to the regulation of companies This Act makes provision about companies and other entities in financial difficulty; and to make temporary changes

This tracker was used to track key developments, legislation, guidance and briefing notes relating to the initial response to coronavirus (COVID-19) between June and August 2020, focusing on updates relevant to local government governance. It is designed to provide a historical record of the legislation and guidance in place and used during that period. For current developments, see: Coronavirus (COVID-19)—governance tracker. Click on the links below to jump to the relevant section: • Primary legislation • National restrictions • Local restrictions • Travel restrictions • Local authority governance • Financial Support • Other legislation • Government guidance • Other sources of information • News Analysis • Case law Primary legislation Development When in force Find out more Corporate Insolvency and Governance Act 2020 Comes into force partly on 26 June 2020, and fully on such day as the Secretary of State may by regulations appoint. Act making provision for companies in financial difficulty and amends to the regulation of companies This Act makes provision about companies and other entities in financial difficulty;

This tracker was used to track key developments, legislation, guidance and briefing notes relating to the initial response to coronavirus (COVID-19) between June and August 2020, focusing on updates relevant to local government governance. It is designed to provide a historical record of the legislation and guidance in place and used during that period. For current developments, see: Coronavirus (COVID-19)—governance tracker [Archived]. Click on the links below to jump to the relevant section: • Primary legislation • National restrictions • Local restrictions • Travel restrictions • Local authority governance • Financial support • Government guidance • Other sources of information • News Analysis • Case Law Primary legislation Development When in force Find out more Corporate Insolvency and Governance Act 2020 (CIGA 2020) Comes into force partly on 26 June 2020, and fully on such day as the Secretary of State may by regulations appoint. Act making provision for companies in financial difficulty and amends to the regulation of companies This Act makes provision about companies and other entities in financial difficulty;

This archived tracker tracked key developments, legislation, guidance and briefing notes relating to the response to coronavirus (COVID-19), focusing on updates relevant to local government governance up until 18 July 2021, when legal restrictions were finally lifted. This Practice Note is archived and is not maintained. For information contained in earlier archived trackers, see: Coronavirus (COVID-19)—governance tracker Summer 2020 [Archived] and Coronavirus (COVID-19)—governance tracker Spring 2020 [Archived]. Click on the links below to jump to the relevant section: • Primary legislation • National restrictions • Local restrictions • Travel restrictions • Local authority governance • Financial support • Government guidance • Other sources of information • News Analysis • Case Law Primary legislation Development When in force Find out more Corporate Insolvency and Governance Act 2020 Comes into force partly on 26 June 2020, and fully on such day as the Secretary of State may by regulations appoint. Act making provision for companies in financial difficulty and amends to the regulation of companies This Act makes provision about companies and other entities in financial

ARCHIVED: This archived Practice Note provides details of the various versions of coronavirus (COVID-19)-related guidance issued by the Department for Business, Energy & Industrial Strategy (BEIS) from 14 July 2021 onwards, and provides tracked change versions, showing the updates between one version and the next, to enable practitioners easily to ascertain which version of the relevant guidance was live at any given date. It is no longer maintained and is for background information only. For information on the versions of this guidance that were published up to 13 July 2021, see Practice Note: Coronavirus (COVID-19)—guidance tracker for employment (BEIS working safely guidance to 18 July 2021) [Archived]. In each case, the versions of the guidance are shown in reverse chronological order, with the most recent appearing first. For a guidance tracker that deals with: • the various versions of current guidance and advice issued by Acas, the Cabinet Office, HMRC, the UK Health Security Agency (UKHSA) (formerly Public Health England (PHE)), the Health and Safety Executive

ARCHIVED: This Practice Note provides details of the various versions of coronavirus (COVID-19)-related guidance issued by the Department for Business, Energy & Industrial Strategy (BEIS), and provides tracked change versions, showing the updates between one version and the next, to enable practitioners easily to ascertain which version of the relevant guidance was live at any given date. It is not maintained and is for background information only. In each case, the versions of the guidance are shown in reverse chronological order, with the most recent appearing first. For a guidance tracker that deals with: • the various versions of the current guidance from BEIS from 14 July 2021, see Practice Note: Coronavirus (COVID-19)—guidance tracker for employment (BEIS working safely guidance to 1 April 2022) [Archived] • the various versions of current guidance and advice issued by Acas, the Cabinet Office, HMRC, the UK Health Security Agency (UKHSA) (formerly Public Health England (PHE)), the Health and Safety Executive (HSE), the Department for Health and Social Care (DHSC) and

ARCHIVED: This Practice Note provides details of the various Coronavirus (COVID-19) international travel and quarantine guidance documents that have been published, and provides tracked change versions, showing the updates between one version and the next, to enable practitioners easily to ascertain which version of the relevant guidance was live at any given date. It is not maintained and is for background information only. Separate sections of the Practice Note cover: • Jobs that qualify for travel exemptions • Test to Release for international travel • Testing before you travel to England • Red list of countries and territories • Travel to England from another country during coronavirus • DHSC: Booking and staying in a quarantine hotel if you’ve been in a red list country • How to self-isolate if you test positive for coronavirus (COVID-19) after international travel • Managed quarantine: what to expect • Employer testing duty • Exemptions from managed quarantine for medical and compassionate reasons In each case, the versions of the guidance are shown in reverse chronological

ARCHIVED: This Practice Note provides details of the various versions of guidance and advice that have been published by Acas, the Cabinet Office, HMRC and UK Health Security Agency (UKHSA) (formerly Public Health England (PHE)), and provides tracked change versions, showing the updates between one version and the next, to enable practitioners easily to ascertain which version of the relevant guidance was live at any given date. It is not maintained and is for background information only. In each case, the versions of the guidance are shown in reverse chronological order, with the most recent appearing first. For a guidance tracker that deals with: • the various versions of current guidance and advice issued by the Department for Business, Energy & Industrial Strategy (BEIS), see Practice Note: Coronavirus (COVID-19)—guidance tracker for employment (BEIS working safely guidance to 1 April 2022) [Archived] and Coronavirus (COVID-19)—guidance tracker for employment (BEIS working safely guidance to 18 July 2021) [Archived] • the various versions of current guidance and advice issued by the UK Border Agency, the Department

ARCHIVED: This archived Practice Note provides details of the various versions of withdrawn or replaced guidance and advice on Coronavirus (COVID-19) that have been published by the Department for Health and Social Care (DHSC), the Department for Business, Energy & Industrial Strategy (BEIS) and the Cabinet Office, and provides tracked change versions, showing the updates between one version and the next, to enable practitioners easily to ascertain which version of the relevant guidance was live at any given date. It is not maintained and is for background information only. Separate sections of the Practice Note cover: • Get coronavirus tests for your employees • How to treat certain expenses and benefits provided to employees during coronavirus • HMRC guidance: Check if you can claim back Statutory Sick Pay paid to employees due to coronavirus (COVID-19) • UKHSA: people with COVID-19 and their contacts • Coronavirus: how to stay safe and help prevent the spread • HSE: Protect vulnerable workers during the coronavirus (COVID-19) pandemic • Managed quarantine: what to expect • DHSC:

ARCHIVED: This archived Practice Note considers the Acas guidance on how to deal with disciplinary and grievance procedures during the coronavirus (COVID-19) pandemic, and the adjustments it suggests that employers may need to make to implement the Acas Code of Practice on Disciplinary and Grievance Procedures (Acas Code) to ensure that any procedure is safe, fair and reasonable. It is not maintained and is for background information only. The existing Information Commissioner’s Office (ICO) Employment Practices Code and supplementary guidance have not been updated to reflect Assimilated Regulation (EU) 2016/679, UK General Data Protection Regulation (UK GDPR) or the Data Protection Act 2018. For information on the ICO’s plans for an Employment Practices Hub, and consultations launched to date in respect of draft guidance, see Practice Note: The UK GDPR and DPA 2018: key data protection issues for employment lawyers—Information Commissioner's Office (ICO) guidance. This Practice Note is based on the information and guidance that has been made available to date, and will be updated to reflect the new ICO guidance